SEC Form 4 · accession 0001209191-17-035290
INTERMOLECULAR INC · IMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lloyd I Miller III
10% Owner
Period of report
May 24, 2017
Accepted (ET)
May 25, 2017 · 2:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311241
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 24, 2017 | P | 107 | $0.85 | A | 2,817,643 | I | By Trust A-4 - Lloyd I. Miller |
| Common StockF1 | holding | — | — | — | 320,136 | I | By Trust A-3 - Lloyd I. Miller | |
| Common StockF1 | holding | — | — | — | 49,318 | I | By LIMFAM LLC | |
| Common StockF1 | holding | — | — | — | 14,149 | I | By Milfam I L.P. | |
| Common StockF1 | holding | — | — | — | 1,780,911 | I | By Milfam II L.P. | |
| Common Stock | holding | — | — | — | 70,368 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Act") or otherwise, the beneficial owner of any equity securities covered by this filing.